Pharmacokinetics and pharmacodynamics of a new cardiotonic vasodilator agent, 349U85, in normal subjects

@article{Clifton1994PharmacokineticsAP,
  title={Pharmacokinetics and pharmacodynamics of a new cardiotonic vasodilator agent, 349U85, in normal subjects},
  author={G. Clifton and M. Harrison and D. Wermeling and R. A. Long and R. Fleck and R. Rolleri and S. Weller and A. Brown and R. Welch},
  journal={Clinical Pharmacology & Therapeutics},
  year={1994},
  volume={55}
}
To assess the pharmacodynamics and pharmacokinetics of single oral doses of a new vasodilator‐cardiotonic agent, 349U85 hydrochloride [6‐piperidino‐2(lH)‐quinolinone hydrochloride], in healthy male subjects. 
1 Citations

References

SHOWING 1-10 OF 14 REFERENCES
Cardiovascular Pharmacology of the Vasodilator‐Cardiotonic Agent, 349U85
Inotropic therapy for heart failure--an unfulfilled promise.
  • G. Curfman
  • Medicine
  • The New England journal of medicine
  • 1991
Electrophysiology of phosphodiesterase inhibitors.
Enoximone in chronic heart failure.
...
1
2
...